Literature DB >> 2109024

Phenotypes and mechanisms in the transformation of hematopoietic cells.

J N Ihle1, K Morishita, C Bartholomew, T Matsugi, D Askew.   

Abstract

Interleukin 3 (IL-3) is a growth factor that supports the proliferation of early hematopoietic stem cells, as well as cells that are committed to a variety of the myeloid lineages. The mechanisms by which IL-3 functions have been studied through the use of a series of IL-3-dependent cell lines isolated from myeloid leukemias or long-term bone marrow cultures. A variety of studies have implicated tyrosine phosphorylation in IL-3 signal transduction. One of the substrates of phosphorylation is a 140 kDa, IL-3-binding protein that is speculated to be the biologically relevant IL-3 receptor. IL-3, through tyrosine phosphorylation, supports viability and growth through the regulation of transcription of a series of genes including c-myc and c-pim-1. The c-myc gene contributes to viability, in part, by regulating the transcription of the ornithine decarboxylase gene. The role of growth factors in differentiation is less clear. By studying IL-3-dependent myeloid leukemia cell lines, two genes have been identified whose altered expression is associated with blocking the ability of the cells to differentiate. The c-myb gene is a nuclear DNA binding protein that has been implicated in myeloid transformation in a number of systems. The Evi-1 gene is a novel gene of the zinc finger family of transcriptional activators. Possible mechanisms by which these genes interfere with normal differentiation are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109024     DOI: 10.1002/stem.5530080712

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  2 in total

1.  The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG.

Authors:  C J Saris; J Domen; A Berns
Journal:  EMBO J       Date:  1991-03       Impact factor: 11.598

2.  Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2.

Authors:  N M van der Lugt; J Domen; E Verhoeven; K Linders; H van der Gulden; J Allen; A Berns
Journal:  EMBO J       Date:  1995-06-01       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.